47 results
6-K
EX-99.1
LEGN
Legend Biotech Corp
22 Apr 24
Current report (foreign)
1:06pm
). Median duration of ICANS was 6 days (range: 1 to 1229 days) in all patients including those with ongoing neurologic events at the time of death or data cut … those with ongoing neurologic events at the time of death or data cut-off. The onset of parkinsonism occurred after CRS for all patients and after
6-K
EX-99.1
LEGN
Legend Biotech Corp
8 Apr 24
Current report (foreign)
7:03am
duration of ICANS was 6 days (range: 1 to 1229 days) in all patients including those with ongoing neurologic events at the time of death or data cut-off … with ongoing neurologic events at the time of death or data cut-off. The onset of parkinsonism occurred after CRS for all patients and after ICANS for 6
6-K
EX-99.1
LEGN
Legend Biotech Corp
15 Mar 24
FDA ODAC votes 11 to 0 supporting favorable risk-benefit assessment of CARVYKTI based on results from the Phase 3 CARITUDE-4 study
3:18pm
with the use of corticosteroids and intravenous immune globulin. Myelitis was ongoing at the time of death from other cause.
Peripheral Neuropathy: Seven … , at the time of death.
Monitor blood counts prior to and after CARVYKTI® infusion. Manage cytopenias with growth factors and blood product transfusion
6-K
EX-99.1
6buj5n2kf 0fdq
23 Feb 24
Current report (foreign)
7:16am
6-K
EX-99.1
mj7co7
11 Dec 23
Legend Biotech Corporation 6-K
7:32pm
6-K
EX-99.1
zsrlavgl7n0 9gnh
6 Jun 23
Legend Biotech Corporation 6-K
4:44pm
6-K
EX-99.1
p2ta7hv
5 Jun 23
Legend Biotech 6-K
11:17am
6-K
EX-99.1
ynbhdyttfv06
25 May 23
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
vzaya s6qubwd4
16 May 23
Legend Biotech Corporation 6-K
8:39am
6-K
EX-99.1
ssac12
21 Apr 23
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
ja85pn 8601
3 Nov 22
Legend Biotech Corporation 6-K
4:09pm
6-K
EX-10.1
oz1qx4tm3 ik6vvdbl
3 Oct 22
Legend Biotech Corporation 6-K
4:02pm
6-K
EX-99.1
f4lfpgjh09b69qwp6
27 Sep 22
Legend Biotech Corp. 6-K
9:17am
6-K
EX-10.1
cts8kqurk8dw7xo4
4 Aug 22
Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board
4:18pm
6-K
EX-1.1
rhosq
27 Jul 22
Announces Pricing of Public Offering
4:35pm
6-K
EX-99.1
upqc7uyv67z3
6 Jun 22
Legend Biotech Corporation Form 6-K
6:00am
6-K
EX-99.1
tt8x io6ny
18 May 22
Legend Biotech Corp. 6-K
8:30am